|
Video: What is a Stock Split?
|
|
Exicure is an early-stage biotechnology company developing nucleic acid therapies targeting ribonucleic acid against validated targets to neurological disorders and hair loss. Co. is focus on realignment of its research and development resources to support the development of its preclinical program targeting SCN9A for neuropathic pain; the development of its partnered programs to develop Spherical Nucleic Acid, or SNA-based treatments in neuroscience targeting Huntington's disease and Angelman syndrome; the development of its partnered program to develop SNA-based treatments for hair loss disorders; and the research and development of other undisclosed therapeutic product candidates. According to our XCUR split history records, Exicure has had 1 split. | |
|
Exicure (XCUR) has 1 split in our XCUR split history database. The split for XCUR took place on June 30, 2022. This was a 1 for 30 reverse split, meaning for each 30 shares of XCUR owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 33.3333333333333 share position following the split.
When a company such as Exicure conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the XCUR split history from start to finish, an original position size of 1000 shares would have turned into 33.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Exicure shares, starting with a $10,000 purchase of XCUR, presented on a split-history-adjusted basis factoring in the complete XCUR split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/23/2018 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$105.00 |
|
End price/share: |
$0.60 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.43% |
|
Average Annual Total Return: |
-58.60% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$57.37 |
|
Years: |
5.85 |
|
|
|
Date |
Ratio |
06/30/2022 | 1 for 30 |
|
|